C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation

C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation

Show other versions (1)

Two consecutive multi-center phase II trials were designed to prove the hypothesis, whether therapeutic modeling of tumor-associated inflammatory processes could result in improved tumor response. Therapy in both trials consisted of low-dose capecitabine 1g/m2 twice daily p.o. for 14 days, every 3 w...

Full description

Bibliographic Details
Main Authors: Albrecht Reichle, Jochen Grassinger, Klaus Bross, Jochen Wilke, Thomas Suedhoff, Bernhard Walter, Wolf-Ferdinand Wieland, Anna Berand, Reinhard Andreesen
Format: Article
Language:English
Published: SAGE Publishing 2006-01-01
Series:Biomarker Insights
Online Access:https://doi.org/10.1177/117727190600100017

Similar Items

Similar Items